SG49876A1 - Recombinant avipox virus, the culture of cells infected with this virus and vaccines for poultry derived from this virus - Google Patents

Recombinant avipox virus, the culture of cells infected with this virus and vaccines for poultry derived from this virus

Info

Publication number
SG49876A1
SG49876A1 SG9608014A SG1996008014A SG49876A1 SG 49876 A1 SG49876 A1 SG 49876A1 SG 9608014 A SG9608014 A SG 9608014A SG 1996008014 A SG1996008014 A SG 1996008014A SG 49876 A1 SG49876 A1 SG 49876A1
Authority
SG
Singapore
Prior art keywords
virus
vaccines
culture
cells infected
recombinant avipox
Prior art date
Application number
SG9608014A
Other languages
English (en)
Inventor
Thiry Georges
Colau Didier
De Wannemaeker Catherine
Malarme Daniel
Original Assignee
Dimminaco Ag Sa Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimminaco Ag Sa Ltd filed Critical Dimminaco Ag Sa Ltd
Publication of SG49876A1 publication Critical patent/SG49876A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455—Eimeria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SG9608014A 1991-05-27 1992-03-19 Recombinant avipox virus, the culture of cells infected with this virus and vaccines for poultry derived from this virus SG49876A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE9100507A BE1004877A3 (fr) 1991-05-27 1991-05-27 Virus de l'avipox recombinant, culture de cellules infectees par ce virus et vaccins pour la volaille derives de ce virus.

Publications (1)

Publication Number Publication Date
SG49876A1 true SG49876A1 (en) 2002-04-16

Family

ID=3885526

Family Applications (1)

Application Number Title Priority Date Filing Date
SG9608014A SG49876A1 (en) 1991-05-27 1992-03-19 Recombinant avipox virus, the culture of cells infected with this virus and vaccines for poultry derived from this virus

Country Status (23)

Country Link
EP (1) EP0517292B1 (ja)
JP (1) JP3411307B2 (ja)
KR (1) KR100244601B1 (ja)
CN (1) CN1055501C (ja)
AR (1) AR248045A1 (ja)
AT (1) ATE189480T1 (ja)
AU (1) AU656185B2 (ja)
BE (1) BE1004877A3 (ja)
BR (1) BR9202024A (ja)
CA (1) CA2069594A1 (ja)
DE (1) DE69230627T2 (ja)
DK (1) DK0517292T3 (ja)
ES (1) ES2145000T3 (ja)
HU (1) HU215531B (ja)
IE (1) IE921686A1 (ja)
IL (1) IL101780A (ja)
MX (1) MX9202512A (ja)
NZ (1) NZ242620A (ja)
PT (1) PT517292E (ja)
RU (1) RU2130971C1 (ja)
SG (1) SG49876A1 (ja)
TW (1) TW288048B (ja)
ZA (1) ZA923321B (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06509235A (ja) * 1991-07-26 1994-10-20 ヴァイロジェネティクス　コーポレイション 伝染性ファブリキウス嚢病ウイルス組換えポックスウイルスワクチン
EP1489165A1 (en) * 1992-01-13 2004-12-22 Virogenetics Corporation Recombinant fowlpox vaccine for protection against marek's disease
FR2697534A1 (fr) * 1992-11-02 1994-05-06 Rhone Merieux Virus herpès de la dinde recombinant pour la réalisation de vaccin de la maladie de Gumboro, son procédé de préparation et vaccin obtenu.
US5925358A (en) * 1993-02-26 1999-07-20 Syntro Corporation Recombinant fowlpox viruses and uses thereof
AU696247B2 (en) * 1993-02-26 1998-09-03 Syntro Corporation Recombinant fowlpox viruses and uses thereof
US6136318A (en) * 1993-02-26 2000-10-24 Cochran; Mark D. Recombinant fowlpox viruses and uses thereof
FR2728795B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire
FR2728794B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro
GB9711957D0 (en) 1997-06-09 1997-08-06 Isis Innovation Methods and reagents for vaccination
GB0118532D0 (en) 2001-07-30 2001-09-19 Isis Innovation Materials and methods relating to improved vaccination strategies
EP1450854A2 (en) 2001-11-30 2004-09-01 Isis Innovation Limited Vaccine
GB2382578A (en) * 2001-11-30 2003-06-04 Isis Innovation Fowlpox-based vaccine
AU2003236646B2 (en) * 2002-05-16 2009-01-15 Bavarian Nordic A/S Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
US7638134B2 (en) * 2003-02-20 2009-12-29 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Insertion sites in fowlpox vectors
GB2402391A (en) * 2003-06-04 2004-12-08 Oxxon Pharmaccines Ltd Fowlpox recombinant genome
PT2785374T (pt) 2011-11-30 2019-05-09 Merial Ltd Vectores recombinantes do herpesvírus 3 dos galídeos (mdv serotipo 2) expressando antigénios de agentes patogénicos aviários e suas utilizações
EP2845904A1 (en) 2013-09-06 2015-03-11 Ceva Sante Animale Recombinant Marek's disease viruses and uses thereof
EP3050572A1 (en) 2015-01-29 2016-08-03 Ceva Sante Animale Recombinant MDV1 and the uses thereof
EP3263129A1 (en) 2016-06-29 2018-01-03 Ceva Sante Animale Duck enteritis virus and the uses thereof
EP3554536B1 (en) 2016-12-14 2022-10-26 Boehringer Ingelheim Animal Health USA Inc. Recombinant hvt vectors expressing multiple antigens of avian pathogens, and vaccines comprising them
BR112021012434A2 (pt) 2018-12-27 2021-09-28 Ceva Sante Animale Vírus recombinantes e usos dos mesmos
CN116472057A (zh) 2020-06-17 2023-07-21 勃林格殷格翰动物保健有限公司 表达流感血凝素的重组hvt载体和免疫原性组合物，以及其生产和用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
EP0314569A1 (fr) * 1987-10-29 1989-05-03 Transgene S.A. Virus du fowlpox recombinant, vecteurs d'expression de protéines héterologues et vaccins pour la volaille dérivés de ce virus
EP0353851A1 (en) * 1988-06-24 1990-02-07 Btg International Limited Fowlpox virus non-essential regions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0419666A4 (en) * 1988-12-29 1991-05-15 Nippon Zeon Co., Ltd. Promoter, plasmid containing the same, and recombinant avipoxvirus
AU643216B2 (en) * 1989-05-30 1993-11-11 Commonwealth Scientific And Industrial Research Organisation Production of IBDV VP2 in highly immunogenic form

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
EP0314569A1 (fr) * 1987-10-29 1989-05-03 Transgene S.A. Virus du fowlpox recombinant, vecteurs d'expression de protéines héterologues et vaccins pour la volaille dérivés de ce virus
EP0353851A1 (en) * 1988-06-24 1990-02-07 Btg International Limited Fowlpox virus non-essential regions

Also Published As

Publication number Publication date
HUT62331A (en) 1993-04-28
IL101780A (en) 2000-12-06
BE1004877A3 (fr) 1993-02-16
IE921686A1 (en) 1992-12-02
ZA923321B (en) 1993-01-27
RU2130971C1 (ru) 1999-05-27
HU9201746D0 (en) 1992-08-28
JPH05244939A (ja) 1993-09-24
TW288048B (ja) 1996-10-11
EP0517292B1 (fr) 2000-02-02
KR920021706A (ko) 1992-12-18
ES2145000T3 (es) 2000-07-01
AU656185B2 (en) 1995-01-27
CN1055501C (zh) 2000-08-16
AU1632392A (en) 1992-12-03
KR100244601B1 (ko) 2000-03-02
JP3411307B2 (ja) 2003-05-26
DE69230627T2 (de) 2000-09-28
PT517292E (pt) 2000-06-30
HU215531B (hu) 2000-05-28
BR9202024A (pt) 1993-01-19
DK0517292T3 (da) 2000-05-08
CN1069068A (zh) 1993-02-17
ATE189480T1 (de) 2000-02-15
EP0517292A1 (fr) 1992-12-09
DE69230627D1 (de) 2000-03-09
NZ242620A (en) 1993-09-27
MX9202512A (es) 1995-01-31
IL101780A0 (en) 1992-12-30
AR248045A1 (es) 1995-05-31
CA2069594A1 (fr) 1992-11-28

Similar Documents

Publication Publication Date Title
SG49876A1 (en) Recombinant avipox virus, the culture of cells infected with this virus and vaccines for poultry derived from this virus
AU2445888A (en) Recombinant fowlpox virus, vectors for the expression of heterologous proteins and vaccines for poultry derived from this virus
DE69016956D1 (de) Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor.
AR241939A1 (es) Metodo para la recombinacion de adn de virus de viruela de ave con adn exogeno.
DE3853088D1 (de) Rekombinantes Avipoxvirus.
GB2246784A (en) Herpes virus recombinant poxvirus vaccine
NO892251D0 (no) Fremgangsmaate ved fremstilling av kokkoidosevaksine ved rekombinante teknikker.
NZ211880A (en) Immunogenic, leukemia-associated viral proteins and vaccines
ZA826154B (en) Infectious bronchitis vaccines for poultry, process for the preparation of such vaccines, process for preventing infectious broachitis and infectious bronchitis virus strain
CA2186044A1 (en) Novel mutated viruses, anti-viral compounds and novel methods of making vaccines
FR2620459B1 (fr) Virus recombinant de la vaccine
EP0597016A4 (en) Infectious bursal disease virus recombinant poxvirus vaccine.
GB2264949B (en) Measles virus recombinant poxvirus vaccine
NZ229679A (en) Recombinant dna sequence encoding an emeria peptide, the peptide and poultry vaccine against coccidiosis
AU4090393A (en) Fowl mycoplasma antigen, gene thereof, recombinant vector containing said gene, and vaccine prepared by utilizing the same
EP0518313A3 (en) Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same
AU6358190A (en) Polypeptide vaccines against foot-and-mouth disease virus
EP0586065A3 (en) Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
WO1997003187A3 (en) Marek's disease virus genes and their use in vaccines for protection against marek's disease
EP0244427A4 (en) RECOMBINANT VIRUS.
WO1992014818A3 (en) Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences
ZA919198B (en) Measles virus recombinant poxvirus vaccine
AU6051396A (en) Measles virus recombinant poxvirus vaccine
ZA906852B (en) Recombinant negative strand rna virus expression-system and vaccines
FR2655855B1 (fr) Protection genetique d'animaux contre l'infection par le virus leucemogene bovin, et provirus et virus recombinant derive de ce virus.